TOP FORME MULTIVITAMINES, COMPRIMES A AVALER
Food supplement declared in France, declaration No 2023-1-1145
TOP FORME MULTIVITAMINES, COMPRIMES A AVALER (JUVAMINE) is a food supplement declared in France. Status: withdrawal from the market announced for 28 October 2029. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- JUVAMINE
- Food business operator placing the product on the market
- Laboratoires JUVA SANTE
- Status
- Withdrawal from the market announced for 28 October 2029
- Form
- Tablet
- Daily dose
- 1 comprimé par jour
- Directions for use
- Au cours du petit- déjeuner, prendre 1 comprimé par jour avec un verre d’eau de 200 mL environ.
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Children (under 12)
- Objectives stated by the manufacturer (these are not authorised claims)
- Nervous system, Immunity
Declaration 191457, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Eleutherococcus senticosus (Rupr. et Maxim.) Maxim | Racine | Extrait sec hydroalcoolique | 10 mg |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| D-pantothénate de calcium | Acide pantothénique (vitamine B5) | pas de limite (données insuffisantes) | dose annulled by the French Council of State in 2011 |
| D-biotine | Biotine (vitamine B8) | pas de limite (données insuffisantes) | dose annulled by the French Council of State in 2011 |
| Carbonate de calcium | Calcium | 2,500 mg | 800 mg |
| Picolinate de chrome | Chrome | pas de limite (données insuffisantes) | 25 µg |
| Sulfate de cuivre | Cuivre | 5,000 µg | 2,000 µg |
| Fumarate ferreux | Fer | 40 mg (safe level) | 14 mg |
| Acide ptéroylmonoglutamique | Folates (vitamine B9) | 1,000 µg | 200 µg |
| Iodure de potassium | Iode | 600 µg | 150 µg |
| Oxyde de magnésium | Magnésium | 250 mg | 300 mg |
| Sulfate de manganèse | Manganèse | 8 mg (safe level) | 3.5 mg |
| Molybdate de sodium | Molybdène | 600 µg | 150 µg |
| Nicotinamide | Nicotinamide (vitamine B3) | 900 mg | 54 mg |
| Sélénite de sodium | Sélénium | 255 µg | 50 µg |
| Acétate de rétinyle | Vitamine A | 3,000 µg d'équivalent rétinol | 800 µg |
| Chlorhydrate de thiamine | Vitamine B1 (thiamine) | pas de limite (données insuffisantes) | dose annulled by the French Council of State in 2011 |
| Cyanocobalamine | Vitamine B12 | pas d'effet indésirable défini | dose annulled by the French Council of State in 2011 |
| Riboflavine | Vitamine B2 (riboflavine) | pas de limite (données insuffisantes) | dose annulled by the French Council of State in 2011 |
| Chlorhydrate de pyridoxine | Vitamine B6 | 12 mg | 2 mg |
| Acide L-ascorbique | Vitamine C | pas de limite (données insuffisantes) | 180 mg |
| Cholécalciférol | Vitamine D | 100 µg (4,000 UI) | 5 µg (200 UI) |
| Acétate de DL-alpha-tocophéryle | Vitamine E | 300 mg | 30 mg |
| Oxyde de zinc | Zinc | 25 mg | 15 mg |
Additives
E420, E460, E470b
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Ne peut remplacer une alimentation variée, équilibrée et un mode de vie sain. Il est recommandé de respecter la dose journalière conseillée. Une consommation excessive peut avoir des effets laxatifs. Conserver dans un endroit frais, sec et à l'abri de la lumière. Tenir hors de portée des jeunes enfants. Réservé à l'adulte. Veiller à ne pas consommer simultanément des compléments alimentaires contenant du sélénium. Pour les femmes enceintes ou allaitantes, il est recommandé de prendre conseil auprès d’un professionnel de santé avant toute supplémentation. Ne pas prendre à jeun.
Regulatory points
- Information
Withdrawal from the market announced for 28 October 2029, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Eleutherococcus senticosus (Rupr. et Maxim.) Maxim
Read the warning, when it applies and the studies cited
ELEUTHERO - ELEUTHEROCOCCUS SENTICOSUS
Route of administration: Oral (ESCOP 2003; Bradley 1992)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Barnes et al. 2007; ESCOP 2003).
Sources cited by Health Canada (2)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an acute infection (Brinker 2010; Mills and Bone 2000).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone; 2000.
Contraindications
Do not use if you have high blood pressure (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000; Mills and Bone 2000).
Sources cited by Health Canada (5)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.
- Mills S, Bone K. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone; 2000.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : JUVAMINE
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.